Portfolio companies.
34,000+ PE-backed.

Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.

Active deals

216

currently held

Exits tracked

hand-checked

Sectors covered

across the portfolio

Countries covered

from every market

Latest activityLast event 2026-09-23

Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week ago

Caledonia Investments1 week ago

Capital Event · capital-cancellation-shares · Capital structure change

capital

Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week ago

Caledonia Investments1 week ago

Capital Event · capital-cancellation-shares · Capital structure change

capital

Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week ago

Caledonia Investments1 week ago

Capital Event · capital-cancellation-shares · Capital structure change

capital

Elaia PartnersadminCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway2 weeks ago

Elaia Partners2 weeks ago

CEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway

admin

Lauxera Capital PartnersadminBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board1 month ago

Company	Sector	Geo	Investor	Entry	Hold	Status	Buyer	MOIC
Elkedonia2 periods Angelini Ventures	Biotech	France	Angelini Ventures	2025	1yr	Active	–	–
Enodia Therapeutics2 periods Elaia Legacy Fund	Biotech	France	Lazard Elaia Capital	2026	0yr	Active	–	–
Epigene Labs2 periods Digital 3	Biotech	France	XAnge	2019	7yr	Active	–	–
Hemarina2 periods We Positive Invest	Biotech	France	Arkea Capital	2014	12yr	Active	–	–
HEPHAISTOS-Pharma2 periods Elaia Digital Venture Fund V	Biotech	France	Lazard Elaia Capital	2024	2yr	Active	–	–
Inside Therapeutics2 periods Newfund HEKA	Biotech	France	Newfund Management	2024	2yr	Active	–	–
Nuevocor2 periods Angelini Ventures	Biotech	France	Angelini Ventures	2021	5yr	Active	–	–
Numi2 periods Heartcore Capital Fund IV	Biotech	France	Heartcore Capital	2023	3yr	Active	–	–
Pharvaris2 periods Kurma Biofund III	Biotech	France	Eurazeo	2019	7yr	Active	–	–
Stalicla2 periods LIFTT	Biotech	France	LIFTT	2021	5yr	Active	–	–
Synendos Therapeutics2 periods Ysios BioFund III	Biotech	France	Ysios Capital Partners	2020	6yr	Active	–	–
Tenpoint Therapeutics2 periods AFB Fund II	Biotech	France	AdBio Partners	2022	4yr	Active	–	–
Whitelab Genomics2 periods Omnes Real Tech 1	Biotech	France	Omnes Capital	2020	6yr	Active	–	–
Xenothera2 periods MH Innov'	Biotech	France	Malakoff Humanis Innov'	2021	5yr	Active	–	–
Zymoptiq2 periods Captech Sante	Biotech	France	Finorpa Gestion	2021	5yr	Active	–	–
ABCELY GOCA3	Biotech	France	Go Capital	2023	3yr	Active	–	–
Advanced BioDesign Xerys Capital France	Biotech	France	Xerys Invest	2016	10yr	Active	–	–
Advesya Jeito I	Biotech	France	Jeito Capital	2022	4yr	Active	–	–
Aelis Farma ACI (Aquitaine Creation Investissement)	Biotech	France	Aquiti Gestion	2016	10yr	Active	–	–
Allogenica Sorbonne Venture	Biotech	France	Aloe Private Equity	2022	4yr	Active	–	–
Allozymes Health for Life Capital	Biotech	France	Seventure Partners	2022	4yr	Active	–	–
AndzonBio AFB Fund II	Biotech	France	AdBio Partners	2024	2yr	Active	–	–
AndzonBio2 AFB Fund II	Biotech	France	AdBio Partners	2025	1yr	Active	–	–
Antaros Medical Lauxera Growth II	Biotech	France	Lauxera Capital Partners	2025	1yr	Active	–	–
Apmonia Cap Innov'Est 2	Biotech	France	Capital Grand Est	2022	4yr	Active	–	–
Apmonia Therapeutics FIRA	Biotech	France	Finovam Gestion	2022	4yr	Active	–	–
Argobio Angelini Ventures	Biotech	France	Angelini Ventures	2021	5yr	Active	–	–
Auressens Erganeo	Biotech	France	Erganeo	2021	5yr	Active	–	–
Aurobac Therapeutics Boehringer Ingelheim Venture Fund	Biotech	France	Boehringer Ingelheim Venture Fund	2023	3yr	Active	–	–
Aviceda Therapeutics Jeito II	Biotech	France	Jeito Capital	2024	2yr	Active	–	–
Axoltis Pharma Angelor	Biotech	France	ANGELOR	2024	2yr	Active	–	–
Azafaros Jeito II	Biotech	France	Jeito Capital	2025	1yr	Active	–	–
BigHat Biosciences Quadrille Technologies IV	Biotech	France	Quadrille Capital	2022	4yr	Active	–	–
Biose Siparex Territoires	Biotech	France	Siparex	2021	5yr	Active	–	–
Brink Therapeutics Breega Seed fund	Biotech	France	Breega	2025	1yr	Active	–	–
Carvolix Truffle BioMedTech	Biotech	France	Truffle Capital	2026	0yr	Active	–	–
CDR-Life Jeito I	Biotech	France	Jeito Capital	2022	4yr	Active	–	–
Certis Therapeutics GSO Innovation	Biotech	France	Grand Sud-Ouest Capital	2020	6yr	Active	–	–
Core Biogenesis Digital 3	Biotech	France	XAnge	2020	6yr	Active	–	–
Curlim AVA 1 (Aquiti Venture Amorcage)	Biotech	France	Aquiti Gestion	2024	2yr	Active	–	–
Dilepix Elaia Alpha II	Biotech	France	Elaia Partners	2020	6yr	Active	–	–
Dillico Angelor	Biotech	France	ANGELOR	2024	2yr	Active	–	–
Ekinnox Elaia DV4	Biotech	France	Elaia Partners	2020	6yr	Active	–	–
Emulseo ACI (Aquitaine Creation Investissement)	Biotech	France	Aquiti Gestion	2017	9yr	Active	–	–
Ermium Kurma Biofund III	Biotech	France	Eurazeo	2019	7yr	Active	–	–
Ervimmune Health for Life Capital	Biotech	France	Seventure Partners	2022	4yr	Active	–	–
Evexta Bio Truffle Capital Legacy (pre-2019)	Biotech	France	Truffle Capital	2013	13yr	Active	–	–
Evora Biosciences Erganeo	Biotech	France	Erganeo	2020	6yr	Active	–	–
Exeliom Biosciences Cap Innov'Est 1	Biotech	France	Capital Grand Est	2017	9yr	Active	–	–
Exobiosphere Expansion SLP	Biotech	France	Expansion Ventures	2024	2yr	Active	–	–

Portfolio companies.34,000+ PE-backed.

Portfolio companies.
34,000+ PE-backed.